Sandoz Loses Challenge To FDA Exclusivity For Sanofi Drug
A Washington, D.C., federal judge has ruled against Novartis unit Sandoz in its suit claiming the U.S. Food and Drug Administration improperly gave exclusivity to a Sanofi multiple sclerosis drug, finding...To view the full article, register now.
Already a subscriber? Click here to view full article